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Introduction
The observation by Lavoisier and LaPlace in 18th
century that muscular contraction consumes oxygen (0,)
and produces carbon dioxide (CO,) had made it possible
to study the mechanisms of exercise performance in
human beings (1). An individual’s capacity to perform in-
creasing levels of dynamic work depends upon the amount
of oxygen that can be delivered to working muscles and
on the capacity of muscles to oxidize substrates. The
structural and physiological integrity of the respiratory,
cardiovascular and muscular systems is essential for
delivery of oxygen to the tissues and removal of carbon
dioxide from the body. Cardio-Pulmonary exercise test-
ing (CPX) is one of the important investigative tools to
evaluate patients with dyspnoea or exercise intolerance
who have pulmonary or cardiac dysfunctions or both and
in the assessment of work impairment. Exercise testing
provides clinically useful information that is not available
at rest. In addition, CPX is recognized as an useful non-
invasive method to evaluate healthy individuals in com-
petitive sports. In order to detect and interpret abnor-
malities during exercise, it is essential that one should
have a knowledge of normal cardio-pulmonary and meta-
bolic responses to exercise.
1. Muscular system
Human skeletal muscle produces high energy
phosphate compounds that are essential to initiate and
sustain forceful contraction. This is achieved by metabo-
lism of nutrients (carbohydrates, fats and proteins) and
the energy thus produced is stored in the form of high-
energy phosphate compounds. Carbohydrates are gen-
erally preferred over fats as a muscle fuel and protein is
used only in severe catabolic states.. Carbohydrate (gly-
cogen or glucose) undergoes glycolysis to form pyruvate.
Pyruvate is then metabolized in the Krebs cycle to gen-
erate substantial adenosine triphosphate (ATP). Subse-
quent reaction in the electron transport chain produces
additional ATP This is achieved by adequate supply of
oxygen to the mitochondria. When oxygen demand ex-
ceeds supply, anaerobic metabolism sets in. Accumula-
tion of lactic acid during anaerobic metabolism along with
hypoxia limits exercise tolerance (2).
Skeletal muscles are composed of two major vari-
eties of contractile cells (2,3). Type I (oxidative or slow
twitch) fibres have prolonged repetitive contraction and
are more resistant to the development of fatigue. Type
Il (glycolytic or fast twitch) fibres have faster contractile
characteristics and fewer oxidative enzymes and are more
easily fatigable. Fibre type distribution in a given muscle
group is fixed by heredity and cannot be modified by train-
ing. Type II fibres are subdivided into three types: i) Ila
fibre with intermediate levels of myoglobin as well as oxi-
dative and glycolytic enzymes, ii) Ilb fibres with low oxi-
dative and high glycolytic enzymes and iii) Ilc fibres which
can differentiate into Ila or Ilb fibre types. Marathon run-
ners have a greater predominanace of slow type (Type I)
fibres while sprinters have a marked increase in fast twitch
(Type II) fibres.
2. Respiratory system
Respiratory system consists of two major compo-
nents: a gas exchanging organ (the lungs) and the pump
that ventilates the lung. The pump consists of chest wall
(rib cage and abdominal compartments), the ventilatory
muscles, the centres in the nervous system and the in-
tervening neural connections. There is a progressive in-
crease in minute ventilation (VE) during incremental ex-
ercise. In younger subjects, tidal volume (VT) increases
during progressive exercise upto approximately 50% of
vital capacity (VC) afterwhich increase in VE are achieved
mainly by increases in the breathing frequency(f) (4). In
older subjects, a greater proportion of VC is used (aver-
age 60%) before VE response becomes predominantly a
frequency response (5). Pulmonary ventilation increases
during exercise in proportion to metabolic rate in order to
achieve alveolar and hence arterial blood gas partial pres-
sures at or close to resting levels. Minute ventilation (VE)
consists of alveolar ventilation (VA) and dead space ven-
tilation (VD). Alveolar ventilation, therefore, is the differ-
ence between the total ventilation of the lung (VE) and
the ventilation of the dead space (VD). Hence
VA = VE - VD
or VA = VE ( 1 -VD/VT)
Where VD/VT is the ratio of physiologic dead space
to tidal volume.
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ln order to maintain alveolar PCO2 and PO, at a
constant level during exercise, VA changes in precise
proportion to carbon dioxide output (VCO2) and oxygen
intake (VO2) (2).
VA = 863 x VCO2 = 863 x VO2
PACO2 (PIO2 - PAO2)
Thus VE = 863 x VCO2
(PACO2 (1 -VD/VT)
where PACO2 and PAO2 are partial pressures of
CO2 and O2 in the alveolar gas respectively and PIO2 is
the partial pressure of O2 in the inspired gas.
Ventilation during muscular exercise is therefore
determined by three variables: PACO2, VD/VT and VCO2.
The ratio of VCO2 to VO2 is defined as respiratory ex-
change ratio: R = VCO2
VO2
2.1 Breathing reserve
Breathing reserve is the difference between the
maximal ventilatory capacity and the maximal ventila-
tion achieved (VE max) during exercise. For practical
purposes, maximal voluntary ventilation (MVV) is con-
sidered equivalent to maximal ventilatory capacity. MVV
can be either measured (12-second MVV) or calculated
(FEV1 x 35). The breathing reserve can be calculated in
the following ways (6) :
difference between the MVV and the maximal minute
ventilation achieved during exercise, MVV-VE max.
percentage of the maximal ventilatory capacity used
during exercise, VE max/MVV and
percentage of the maximal ventilatory capacity that
remains available after a maximal exercise test, MVV
- VE max/MVV.
3. Cardiovascular system
The cardiac output is defined by Fick’s principle
as:
Q =   VO2
CaO2 - CvO2
Where Q is the cardiac output and CaO2 and CvO2
are the concentrations of oxygen in arterial and mixed
venous blood respectively. A rearrangement of this equa-
tion results in :
VO2 = Q (CaO2 - CvO2)
= HR x SV x (CaO2 - CvO2)
VO2/HR = SV x (CaO2 - CvO2)
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where HR is heart rate and SV is stoke volume,
Oxygen pulse (VO2/HR) is therefore oxygen con-
sumption per heart beat. A plateau in O2 pulse during an
exercise test is achieved when the maximum oxygen ex-
tract ion and maximum stroke volume have been
achieved. If oxygen extraction is assumed to be normal,
O2 pulse represents an estimate of stroke volume (2)
Normally heart rate and VO2 are linearly related during
incremental exercise testing. The difference between pre-
dicted and attained maximal heart rate is defined as the
estimated heart rate reserve (7).
Systemic arterial blood pressure rises during ex-
ercise to levels around 200 mm Hg in maximal exercise.
The rise in diastolic pressure is much less (to around 90
mm Hg) and mean arterial pressure increases from 90
mm Hg at rest to 140 mm Hg in maximal exercise (8).
There is considerable fall in systemic peripheral vascu-
lar resistance due to marked vasodilation in working
muscles. Pulmonary vascular resistance alsofalls con-
siderably during exercise with the rise in mean pulmo-
nary artery pressure of 15 mm Hg or less in young adults
(8).
4. Pulmonary gas exchange
Pulmonary gas exchange during exercise is evalu-
ated by measuring the alveolar - arterial oxygen pres-
sure difference (P(A-a)O2) and the physiological dead
space to tidal volume ratio (VD/VT). The equation for the
measurements of P(A-a)O2 and VD/VT ratio are as fol-
lows (9,10):
P (A-a)O2 = PIO2 - (PaCO2 x (FIO2 + 1 -FIO2) - PaO2
R
where PIO2 is the partial pressure of O2 in the in-
spired gas and FIO2 is the fractional concentration of
oxygen in the inspired gas (dry).
(PaCO2 - PECO2) / PaCO2 X VT - valve VD
VT
where PECO2 is the partial pressure of CO, in the
expired gas.
5. Cardio-Pulmonary exercise testing
The equipments required for cardio-pulmonary ex-
ercise testing include treadmill or cycle ergometer, flow
meters, gas analyzers and electrocardiographs(11). Four
primary signals (flow, oxygen, carbon dioxide and elec-
trocardiogram) are obtained by these equipments. Flow
meter that is commonly used is pneumotachometer and
other flow devices are anemometer and turbine flow
meters. The most accurate gas analyzer is a mass spec-
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trometer which can measure simultaneously all respira-
tory gases (O2, CO2 and nitrogen(N2)). However, it is the
most expensive equipment. Oxygen can also be deter-
mined either by fuel cell analyzer (zirconium electrochemi-
cal cell) or paramagnetic analyzer. Fuel cell analyzer
measures the difference in electrical potential across the
membrane induced by the presence of O2. It is inexpen-
sive, reliable and accurate, but is slow responding. Para-
magnetic analyzer determines O2 on the basis of its prop-
erty to distort a magnetic field. Since CO, has the prop-
erty of absorbing infrared radiation, infrared analyzers are
used for the analysis of CO,.
Expired respiratory gases are analyzed either by
a mixing chamber (12) or breath-by-breath analysis (13).
In a mixing chamber, the exhaled gas which consists of
dead space and alveolar air is mixed with baffles to ob-
tain actual expired gas. A representative sample of the
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20 seconds of expired gas is analyzed and used with
flow to make the calculations. In this system, end-tidal
measurements (PETO2 and PETCO2) cannot be made.
In the breath-by-breath analysis system, the four signals
are aligned and each expiration is sampled at a rate of
100 to 120 times per second,. The flow, O2 and CO2 of
each sample are then integrated to obtain ventilation,
oxygen consumption and CO2 production for each breath.
The exercise testing can be done using either a
treadmill or a cycle ergometer. Even though several tread-
mill protocols are available, the most widely used proto-
cols are the Bruce (14) and the Balke (15). The measure-
ments that are made during cardio-pulmonary exercise
testing are listed in Table 1 and the suggested normal
maximum cardio-pulmonary variables for cycle exercise
testing in adults (16) are described in Table 2.
Table 1
Measurements during cardiopulmonary exercise testing
Metabolic
1. Oxygen uptake (VO2)
2. Carbon dioxide output (VCO2)
3. AnaerobicThreshold (AT)
4. Respiratory exchange ratio (R)
Respiratory
1. Minute ventilation (VE)
2. Tidal volume (VT)
3. Respiratory Frequency (f)
4. Ratio of tidal volume to vital capacity (VT/VC)
Cardiovascular
1. Electrocardiogram
2. Oxygen pulse (VO2/HR)
3. Blood pressure
4. VO2/Work rate
Pulmonary gas exchange
1. Arterial oxygen saturation (SaO2)
2. Arterial partial pressure oxygen (PaO2)
3. Alveolar to arterial oxygen tension difference [P(A-a)O2]
4. Ratio of physiologic dead space to tidal volume (VD/VT)
5. Arterial to end tidal CO, tension difference [P(a-ET)CO2]
6. Ventilatory equivalent for oxygen (VE/VO2)
7. Ventilatory equivalent for CO2 (VE/VCO2)
Acid-base balance
1. pH
2. PaCO2
3. HCO3
4. Lactate
(Source: Reference 6)
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5.1. Maximal Oxygen consumption
The maximal oxygen consumption (VO2 max) or
aerobic capacity is the highest oxygen uptake during
exhaustive exercise of large muscle mass. Maximal oxy-
gen consumption is reached when O2 uptake-does not
increase, but plateaus or decreases despite further in-
crease in power (17). The VO2 max is achieved during
exercise testing when there is increase of less than 0.15
I/min or 2.1 ml/kg/min with a further increase in treadmill
elevation of 2.5%(6). The VO2 measured at maximal ex-
ercise without reaching a plateau is called VO2 peak (6).
In order to assume that the individual has reached the
VO2 peak, one of the following requirements must oc-
cur (6,18): i) patient must look exhausted, ii) heart rate or
VE must be close to the maximal predicted values, iii)
lactate is greater than 8m Eq/l or iv) respiratory exchange
ratio is greater than 1.15. In clinical practice VO2 peak
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and VO2 max are used interchangeably. VO2 max mea-
sured during running on a treadmill is normally 10% higher
than that determined on a cycle ergometer. VO2 is ex-
pressed in liters per minute. It can also be expressed by
normalizing VO2 for body weight (as ml/kg/min) and for
square meter of body surface area (ml/m2/mm). VO2 should
be expressed both in absolute units (I/mm) and in the
normalized fashion.
5.2. Anaerobic threshold
Anaerobic threshold is defined as the level of
exercise VO2 above which aerobic energy production is
supplemented by anaerobic mechanisms and is associ-
ated with a significant increase in the lactic acid produc-
tion (19). The different methods of determining anaerobic
threshold is listed in Table 3.
Table 2
Guidelines for normal maximum cardiopulmonary exercise variables in adults.
V O 2  R e s p o n s e s
VO2 max
Anaerobic threshold
Heart Response
O2 pulse
Heart rate reserve (beats/min)
Blood pressure
B r e a t h i n g  R e s p o n s e s
Breathing reserve
VT/VC
Frequency (breaths/min)
Pulmonary Gas Exchange (peak values)
VE/VCO2 at anaerobic threshold
VD/VT
P(a-ET)CO2
PaO2
P(A-a)O2
> 84% predicted
> 40% VO2 max predicted
> 80%
< 15 bpm
< 220/90
VEmax/MVV>75%; MVV-VEmax>11L
< 55
< 60 brpm
< 34
< 0.28
< 0
> 80 mm Hg
< 35 mm Hg
(Source: Reference 16).
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Methods for the determination of anaerobic threshold
1. Noninvasive determination
a) Conventional (Ventilatory threshold),
VE/VO2, VE/VCO2, PETO2, PETCO2, R.
b) Ventilatory equivalents threshold
VE/VO2 and VE/VCO2
c) V-slope (gas exchange threshold)
VCO2 vs VO2 (computerized)
d) Modified V-slope (gas exchange threshold)
VCO2 vs VCO2 (Manual)
2. Invasive determination
a) Lactate threshold
Ordinary plot: Lactate vs VO2 or power or time.
Logarithm of lactate vs logarithm of VO2.
b) Bicarbonate threshold
Ordinary plot: Standard HCO3 vs VO2 or power or time.
Logarithm of standard HCO3 vs logarithm
of VO2.
(Source: Reference 6)
5.2.1. Conventional methods 52.2. V slope method
Simultaneous analysis of ventilatory equivalent for
O2 (VE/VO2), ventilatory equivalent for CO2 (VE/VCO2),
end t idal  O2  tension (PETO2) ,  end t idal  CO,
tension (PETCO2) and respiratory exchange ratio(R) is
used in the conventional method to determine AT (20). At
anaerobic threshold, excess production of CO2 stimulates
ventilation (VE) leading to an increase in VE/VO2 and
PETO2 without a change in VE/VCO2 and PETCO2. This
is due to the fact that VE increases proportionally to VCO2
and metabolic acidosis has not yet developed. This lasts
for 2 minutes and is called isocapnic buffering. As exer-
cise proceeds, there is further increasein lactic acid pro-
duction. This results in metabolic acidosis which is an
additional stimulus to increase ventilation out of propor-
tion to VCO2. This leads to an increase in VE/VCO2 and a
decrease in PETCO2. At the point at which VCO2 is pro-
duced in excess of VO2, the respiratory exchange ratio(R)
is around 1. AT is thus determined by looking for the
lowest point (nadir) of VE/VO2 and PETO2 before they
begin to rise consistently coinciding with an unchanged
VE/CO2 and PETCO2 with a R of around 1. VO2 corre-
sponding to this point is AT. This is also called ventilatory
threshold. If AT is determined using only VE/VO2 and VE/
VCO2, it is called ventilatory equivalent threshold.
Conventional method may not be accurate in
situations where there is abnormal control of breathing or
of mechanical derangements of the lungs (as in COPD)
as the lungs are not able to increase the ventilation. In
these situations, V slope method based on the direct
measurement of VCO2 and its relation to the VO2 is
used (21). Before AT, there is a linear relationship between
CO2 production and O2 uptake and at anaerobic thresh-
old, the excess production of CO2 is related to lactic acid
production and not to O2. As a result, the slope of the
VCO2 versus VO2 relationship changes and becomes
steeper. The VO2 at which the change in slope occurs is
AT. Mathematical calculations can be done by a com-
puter and this method is also called gas exchange thresh-
old. When AT is measured manually for VCO2 and VO2
measurements, it is known as modified\/-slope method.
In this method, the VCO2 is plotted against VO2 and a line
parallel to the line of identity is drawn through VCO2 vs
VO2 points during the incremental plan of the exercise
test. The point at which the VCO2 departs from the line
(begins to increase more rapidly than O2) is taken as the
V slope AT and the VO2 corresponding to this point is the
AT.
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Cardiopulmonary exercise testing is emerging as
an important investigative modality to evaluate patients
with dyspnoea on exertion because it is found to be use-
ful to differentiate cardiac from ventilatory causes of
exertional dyspnoea (22). It also helps to identify
psychogenic dyspnoea. By determining anaerobic thresh-
old and VO2 max during CPX, it is possible to detect
impaired cardiac function and to assess severity of
chronic heart failure (23). CPX can also be used to evalu-
ate the efficacy of long-term treatment of heart failure.
CPX provides useful information inpatients with pulmo-
nary hypertension secondary to pulmonary vascular dis-
ease (24). Early diagnosis and monitoring of treatment
are also possible with CPX in patients with interstitial
lung disease (25). In COPD, it is possible to assess ex-
ercise limitation and physiological factors that contribute
to exercise limitation (26). Pulmonary rehabilitation is
another important area where the cardiopulmonary exer-
cise testing enables us to measure exercise tolerance,
assess causes of exercise limitation and screen for ex-
ercise-induced asthma (27). Clinical exercise testing is
also increasingly used in the evaluation of impairment
and disability (28) and of preoperative evaluation of pa-
tients for lung resection (29,30). It also provides objec-
tive guidelines for cardiac transplantation (31) and as-
sessment of functional outcome in recipients of lung and
heart and lung transplantations (32).
Establishment of normative prediction equations
is essential for interpretation of CPX (33). There are not
many publications from our country on CPX (34-37).
Therefore, studies from normal subjects, in addition to
data from various cardio-pulmonary diseases are required
urgently from India.
REFERENCES
1.
2.
3.
4.
5.
6.
7.
Snell PG, Mitchell JH. The role of maximal oxygen uptake in
exercise performance. Clin chest Med 1984; 5: 51-62.
Whipp BJ. The bioenergetic and gas exchange basis of exer-
cise testing. Clin chest Med 1994; 15: 173-192.
Edwards R, Young A, Wiles A. Needle biopsy of skeletal muscle
in the diagnosis of myopathy and the clinical study of muscle
function and repair. N Engl J Med 1980; 302: 261-270.
Younes M, Kivinen G: Respiratory mechanics and breathing
pattern during and following maximal exercise. J Appl Physiol
1984; 57: 1773-8.
Johnson BD, Badr S, Dempsey JA. Impact of the aging pulmo-
nary system on the response to exercise. Clin chest Med
1994; 15: 229-246.
Zeballos RJ, Weisman IM : Behind the scenes of Cardiopul-
monary exercise testing. Clin Chest Med 1994; 15: 193-213.
Wassermann K, Hansen JE, Sue DY: Principles of Exercise
Testing and Interpretations, ed: 1 Philadelphia, Lea &
Febiger, 1987.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
Lung India (1997), XV, No.3 (P. 105-11),
Jones NL: Physiology of exercise. ln: Clinical exercise testing
Ed: Jones NL. 3rd Edition. WB Saunders Company, Philadelphia
1988; p 13-73.
Fenn WO, Rahn H, Otis AB: A theoretical study of the alveolar
air at altitude. Am J Physiol 1946; 146: 637-653.
Bohr C. Ueber die lungenathmung. Skand Arch Physiol. 1891; 2:
236-268.
Clausen JL: Pulmonary function testing guidelines and con-
troversies. New York, Academic Press, 1982.
Jones NL: Conduct of stage 2, 3 and 4 exercise tests. In:
Clinical exercise testing, ed: Ed: Jones NL. 3rd Edition, WB
Saunders Company, Philadelphia 1988; p 186-207.
Beaver WL, Lamarra N, Wasserman K: Breath- by-breath
measurement of true alveolar gas exchange. J Appl Physiol
1981; 51: 1662-1675.
Bruce RA, McDonough JR: Stress testing in screening for
cardiovascular disease. Bull NY Acad Med. 1969; 45: 1288.
1305.
Blake B, Ware R. An experimental study of physical fitness of
Air Force personnel. US Armed Forces Med J 1959; 10: 675-
688.
Weissman IM, Zeballos RJ. An integrated approach to the
interpretations of cardio- pulmonary exercise testing. Clin
Chest Med 1994; 15: 421-445.
Shephard RJ, Allen C, Benade AJS: The maximum oxygen
intake- an international reference standard of cardio- respira-
tory fitness. Bull World Health Organisation 1968; 38: 757-764.
Shephard RJ. Tests of maximum oxygen intake: A critical
review. Sports Med 1984; 1: 99-124:
Wasserman K. The anaerobic threshold measurement in ex-
ercise testing. Clin Chest Med 1984; 5: 77-88.
Wasserman K, Whipp BJ: Exercise physiology in health and
disease. Am Rev Respir Dis 1975; 112: 219-249.
Beaver WL, Wasserman K, Whipp BJ. A new method for de-
tecting the anaerobic threshold by gas exchange. J Appl Physiol
1986; 60: 2020-7.
Mohler DA, Horowitz. Clinical evaluation of exertional
dyspnoea. Clin Chest Med 1994; 15: 259-269.
Weber KT, Janicki JS. Cardiopulmonary exercise testing.
Physiological principles and clinical applications, Philadelphia.
WB Saunders 1986.
Janicki JS, Weber KT, Likoff MJ, Fishman AP Exercise test-
ing to evaluate patients with pulmonary vascular disease. Am
Rev Respir Dis 1984; 129 (Suppl):93-95.
Marciniuk DD, Watts RE, Gallagher CG. Reproducibility of
incremental maximal cycle ergometer testing in patients with
restrictive lung disease. Thorax 1993; 48: 894-898.
Gallagher CG. Exercise and chronic obstructive pulmonary
disease. Med Clin North Am 1990; 74: 619-641.
Belman MJ. Exercise in chronic obstructive pulmonary dis-
ease. Clin Chest Med 1986; 7: 585-597.
Oren A, Sue DY, Hansen JE. The role of exercise testing in
impairment evaluation. Am Rev Respir Dis 1987; 135: 230-5.
Vijayan VK: CPX testing 111
29.
30.
31.
32.
Nakagawa K, Nakahara K, Miyoshi S, Kawashima Y. Oxygen
transport during incremental exercise load as a predictor of
operative risk in lung cancer patients. Chest 1992; 101: 1369-
1375.
Older P, Smith R, Courtney P, Hone R. Preoperative evalua-
tion of cardiac failure and ischemia in elderly patients by
cardiopulmonary exercise testing. Chest 1993; 104: 701-704.
Tjahja IE, Reddy HK, Janicki JS, Weber KT. Evolving role of
cardiopulmonary exercise testing in cardiovascular disease.
Clin Chest Med 1994, 15: 271-285.
Theodore J, Mortin AJ, Burke CM, Glanville AR, Vankessel A,
Baldwin JC, Stinson EB, Shumway NE, Robin ED. Cardiopul-
monary function at maximum tolerable constant work rate
exercise following human heart - lung transplantation. Chest
1987; 92 433-439.
33. Sue DY, Hansen EH. Normal values in adults during exercise
Clin Chest Med 1984; 5: 89-98.
34. Jain AK, Jain SK, Bhatnagar OP. Cardiorespiratory responses
to steady state exercise in sedentary men 20-39 years old
Ind J Chest Dis & All Sci. 1983; 25: 172-185.
35. Sen Gupta J, Srinivasulu N, Sampath KT, Malhotra MS
influence of age on maximum VO, and maximal heart rate of
Indians during work. Ind J Med Res 1974; 62: 1228-1232.
36. Chatterjee S, Banerjee PK, Chatterjee P, Mitra SH: Aerobic
capacity of young girts. Ind J Med Res: 1979; 69: 327-333.
37. Swaminathan S, VijayanVK, Venkatesan P, Kuppurao KV. Aero-
bic capacity and cardiopulmonary response to exercise in
healthy South Indian Children. Indian Paediatrics. 1997; 34: 112-
118.
